Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 1,427 shares at $33.44 ($48K) on 2015-11-24, disclosed to the SEC on 2015-11-25.
Open-market sale of $48k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.25 | 605 | $20K | 42.3% |
| 2 | $33.27 | 36 | $1K | 2.5% |
| 3 | $33.28 | 59 | $2K | 4.1% |
| 4 | $33.34 | 100 | $3K | 7.0% |
| 5 | $33.35 | 127 | $4K | 8.9% |
| 6 | $33.41 | 200 |
| $7K |
| 14.0% |
| 7 | $33.42 | 3 | $100 | 0.2% |
| 8 | $33.43 | 197 | $7K | 13.8% |
| 9 | $33.44 | 100 | $3K | 7.0% |
| Total | $33.33 avg | 1,427 | $48K | 100% |
| Filing → |
| HSKA | SELL | 2017-06-01 | $2.2M | — | Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |